Cytosorbents (CTSO) Other Working Capital Changes (2010 - 2026)
Cytosorbents (CTSO) posted Other Working Capital Changes of -$1000.0 for Q1 2026, up 99.88% on a QoQ basis from -$802000.0 in Q4 2025, and up 99.6% year-over-year from -$501.0 in Q1 2025.
Cytosorbents (CTSO) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Cytosorbents' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 99.6% year-over-year to -$1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 342.74% YoY) and the FY2025 annual result came in at -$1.8 million, down 179000.0% from the prior year.
- Other Working Capital Changes was -$1000.0 for Q1 2026 at Cytosorbents, up from -$802000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $908000.0 in Q3 2025 and bottomed at -$1.6 million in Q2 2025.
- A 5-year average of -$169116.5 and a median of -$1000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 90900.0% in 2025, while the deepest fall reached 80300.0% in 2025.
- Cytosorbents' Other Working Capital Changes stood at $75413.0 in 2022, then jumped by 253.18% to $266343.0 in 2023, then sank by 99.62% to $1000.0 in 2024, then slumped by 80300.0% to -$802000.0 in 2025, then jumped by 99.88% to -$1000.0 in 2026.
- Business Quant data shows CTSO's Other Working Capital Changes at -$1000.0 in Q1 2026, -$802000.0 in Q4 2025, and $908000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -802,000.00 |
| Dec 31, 2025 | -802,000.00 |
| Dec 31, 2025 | -802,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -250,000.00 |
| Mar 31, 2025 | -250,000.00 |
| Mar 31, 2025 | -250,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |